Characterization of the topoisomerase II-induced cleavage sites in the c-myc proto-oncogene
- 1 December 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (24) , 4409-4413
- https://doi.org/10.1016/0006-2952(86)90756-2
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavageBiochemistry, 1986
- Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumorsCell, 1985
- In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatinCell, 1985
- Novel partitioning of DNA cleavage sites for Drosophila topoisomerase IICell, 1985
- A type-II DNA topoisomerase and a catenating protein from the transplantable VX2 carcinomaEuropean Journal of Biochemistry, 1985
- THE MOLECULAR GENETICS OF CELLULAR ONCOGENESAnnual Review of Genetics, 1984
- Absence of swiveling at sites of intercalator-induced protein-associated deoxyribonucleic acid strand breaks in mammalian cell nucleoidsBiochemistry, 1984
- Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factorCell, 1983
- Amplification and expression of the c-myc oncogene in human lung cancer cell linesNature, 1983
- Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell lineNature, 1982